Ovarian Cancer
INCB123667-305 - A Phase 3, Randomized, Open-Label Study of INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression (MAESTRA 2)
- Details
ClinicalTrials.gov ID:
NCT07214779
Diagnosis Type:
NA
USOR Number:
- Address
,
P: